(Q71132678)
Statements
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia (English)
Amadori S
Picardi A
Fazi P
Testi AM
Petti MC
Montefusco E